Your session is about to expire
← Back to Search
Berinert for Kidney Damage
Study Summary
This trial is testing a drug to see if it can prevent kidney damage in people who are at high risk for it. The trial is double-blind, meaning that neither the participants nor the researchers will know who is receiving the drug and who is receiving the placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an active cancer diagnosis.My kidney match is perfect.You are allergic to C1INH treatment.I have tested positive for Hepatitis B, Hepatitis C, or HIV.My blood type matches the donor's for the transplant.I received a kidney transplant that meets specific high-risk criteria.I received a kidney transplant before starting dialysis.My kidney transplant was preserved on a pump before surgery.I am between 18 and 70 years old, on dialysis, and can receive a kidney transplant.I am not pregnant and use reliable birth control.I have received a transplant of a kidney and another organ.I haven't taken C1INH products in the last 15 days.I have a blood clotting disorder.I have a history of blood clots, but not from IV access issues.I am not pregnant or breastfeeding.My blood does not clot properly, and I am not on blood thinners.I received a kidney transplant from a living donor.
- Group 1: Berinert
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are patients over the age of 35 eligible for this study?
"Eligibility for this study includes being between 18-70 years old, as specified in the inclusion criteria."
Are volunteers needed for this research project?
"No, this specific trial is not currently recruiting patients. According to the clinicaltrials.gov website, this study was first posted on March 3rd 2021 and was last edited on January 5th 2022. There are 625 other trials that are actively enrolling participants."
Might I be eligible to participate in this research?
"This study is looking for 40 people, aged 18 to 70, who have kidney diseases. Participants must also meet the following criteria:-Women of childbearing potential must have a negative pregnancy test prior to randomization, and must be on an acceptable form of birth control.-Adult men or women (18-70 years of age) who are on chronic dialysis therapy and acceptable candidates for receipt of a kidney transplant.-Recipients who are ABO compatible with donor allograft.-Understand and sign a written inform consent prior to any study specific procedure.In addition, recipients must"
Is Berinert a common medication in research trials?
"There are two ongoing clinical trials involving Berinert and none of them have reached Phase 3 yet. The majority of the research is being conducted in Los Angeles, California; however, there are four total locations running these trials."
Is this a new or unique study?
"Takeda sponsored the initial 106 person Phase 2 trial for Berinert in 2021. Since then, 18310 other clinical trials have been completed. Right now, there are two active studies being conducted for Berinert across 1 city and 2 countries."
How many people are chosen to participate in this trial?
"As of right now, this study is not looking for any more patients. The trial was first posted on March 3rd 2021 and updated January 5th 2022. For those still interested, there are 623 other trials concerning kidney diseases and 2 involving Berinert that are enrolling participants as we speak."
Share this study with friends
Copy Link
Messenger